Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion type Assertion NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_head.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion description "[Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion evidence source_evidence_literature NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion SIO_000772 23441129 NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion wasDerivedFrom befree-2016 NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.
- NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_assertion wasGeneratedBy ECO_0000203 NP1056021.RA6OEhrwIZ4IdK0K5CccESv0z62L_KENMdIGMqr1-_A94130_provenance.